Emily L Newman1, Georgia Gunner2, Polly Huynh2, Darrel Gachette2, Stephen J Moss3, Trevor G Smart4, Uwe Rudolph5,6, Joseph F DeBold2, Klaus A Miczek2,3. 1. Department of Psychology, Tufts University, Medford, Massachusetts. emily.newman@tufts.edu, ELnewman@gmail.com. 2. Department of Psychology, Tufts University, Medford, Massachusetts. 3. Department of Neuroscience, Tufts University, Boston, Massachusetts. 4. Department of Neuroscience, Physiology and Pharmacology, University College London, London, United Kingdom. 5. Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, Massachusetts. 6. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND: Alcohol use disorders are associated with single-nucleotide polymorphisms in GABRA2, the gene encoding the GABAA receptor α2-subunit in humans. Deficient GABAergic functioning is linked to impulse control disorders, intermittent explosive disorder, and to drug abuse and dependence, yet it remains unclear whether α2-containing GABAA receptor sensitivity to endogenous ligands is involved in excessive alcohol drinking. METHODS: Male wild-type (Wt) C57BL/6J and point-mutated mice rendered insensitive to GABAergic modulation by benzodiazepines (BZD; H101R), allopregnanolone (ALLO) or tetrahydrodeoxycorticosterone (THDOC; Q241M), or high concentrations of ethanol (EtOH) (S270H/L277A) at α2-containing GABAA receptors were assessed for their binge-like, moderate, or escalated chronic drinking using drinking in the dark, continuous access (CA) and intermittent access (IA) to alcohol protocols, respectively. Social approach by mutant and Wt mice in forced alcohol abstinence was compared to approach by EtOH-naïve controls. Social deficits in forced abstinence were treated with allopregnanolone (0, 3.0, 10.0 mg/kg, intraperitoneal [i.p.]) or midazolam (0, 0.56, 1.0 mg/kg, i.p.). RESULTS: Mice with BZD-insensitive α2-containing GABAA receptors (H101R) escalated their binge-like drinking. Mutants harboring the Q241M point substitution in Gabra2 showed blunted chronic intake in the CA and IA protocols. S270H/L277A mutants consumed excessive amounts of alcohol but, unlike wild-types, they did not show forced abstinence-induced social deficits. CONCLUSIONS: These findings suggest a role for: (i) H101 in species-typical binge-like drinking, (ii) Q241 in escalated chronic drinking, and (iii) S270 and/or L277 in the development of forced abstinence-associated social deficits. Clinical findings report reduced BZD-binding sites in the cortex of dependent patients; the present findings suggest a specific role for BZD-sensitive α2-containing receptors. In addition, amino acid residue 241 in Gabra2 is necessary for positive modulation and activation of GABAA receptors by ALLO and THDOC; we postulate that neurosteroid action on α2-containing receptor may be necessary for escalated chronic EtOH intake.
BACKGROUND: Alcohol use disorders are associated with single-nucleotide polymorphisms in GABRA2, the gene encoding the GABAA receptor α2-subunit in humans. Deficient GABAergic functioning is linked to impulse control disorders, intermittent explosive disorder, and to drug abuse and dependence, yet it remains unclear whether α2-containing GABAA receptor sensitivity to endogenous ligands is involved in excessive alcohol drinking. METHODS: Male wild-type (Wt) C57BL/6J and point-mutated mice rendered insensitive to GABAergic modulation by benzodiazepines (BZD; H101R), allopregnanolone (ALLO) or tetrahydrodeoxycorticosterone (THDOC; Q241M), or high concentrations of ethanol (EtOH) (S270H/L277A) at α2-containing GABAA receptors were assessed for their binge-like, moderate, or escalated chronic drinking using drinking in the dark, continuous access (CA) and intermittent access (IA) to alcohol protocols, respectively. Social approach by mutant and Wt mice in forced alcohol abstinence was compared to approach by EtOH-naïve controls. Social deficits in forced abstinence were treated with allopregnanolone (0, 3.0, 10.0 mg/kg, intraperitoneal [i.p.]) or midazolam (0, 0.56, 1.0 mg/kg, i.p.). RESULTS:Mice with BZD-insensitive α2-containing GABAA receptors (H101R) escalated their binge-like drinking. Mutants harboring the Q241M point substitution in Gabra2 showed blunted chronic intake in the CA and IA protocols. S270H/L277A mutants consumed excessive amounts of alcohol but, unlike wild-types, they did not show forced abstinence-induced social deficits. CONCLUSIONS: These findings suggest a role for: (i) H101 in species-typical binge-like drinking, (ii) Q241 in escalated chronic drinking, and (iii) S270 and/or L277 in the development of forced abstinence-associated social deficits. Clinical findings report reduced BZD-binding sites in the cortex of dependent patients; the present findings suggest a specific role for BZD-sensitive α2-containing receptors. In addition, amino acid residue 241 in Gabra2 is necessary for positive modulation and activation of GABAA receptors by ALLO and THDOC; we postulate that neurosteroid action on α2-containing receptor may be necessary for escalated chronic EtOH intake.
Authors: K Löw; F Crestani; R Keist; D Benke; I Brünig; J A Benson; J M Fritschy; T Rülicke; H Bluethmann; H Möhler; U Rudolph Journal: Science Date: 2000-10-06 Impact factor: 47.728
Authors: Jonathan Covault; Joel Gelernter; Victor Hesselbrock; Maggie Nellissery; Henry R Kranzler Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2004-08-15 Impact factor: 3.568
Authors: A R Lingford-Hughes; P D Acton; S Gacinovic; J Suckling; G F Busatto; S J Boddington; E Bullmore; P W Woodruff; D C Costa; L S Pilowsky; P J Ell; E J Marshall; R W Kerwin Journal: Br J Psychiatry Date: 1998-08 Impact factor: 9.319
Authors: Danielle T Arena; Herbert E Covington; Joseph F DeBold; Klaus A Miczek Journal: Psychopharmacology (Berl) Date: 2019-02-23 Impact factor: 4.530
Authors: Emily L Newman; Lucas Albrechet-Souza; Peter M Andrew; John G Auld; Kelly C Burk; Lara S Hwa; Eric Y Zhang; Joseph F DeBold; Klaus A Miczek Journal: Psychopharmacology (Berl) Date: 2018-04-25 Impact factor: 4.530
Authors: Emily L Newman; Herbert E Covington; Michael Z Leonard; Kelly Burk; Klaus A Miczek Journal: Biol Psychiatry Date: 2021-06-01 Impact factor: 12.810